Amgen’s High Hopes: A Biotech Titan Faces New Realities
Amgen Inc. (AMGN) finds itself at a critical juncture in the biotech landscape, balancing robust fundamentals against a backdrop of […]
Amgen Inc. (AMGN) finds itself at a critical juncture in the biotech landscape, balancing robust fundamentals against a backdrop of […]